Reckitt Benckiser Group (LON:RKT) Sets New 1-Year High – Here’s What Happened

Reckitt Benckiser Group plc (LON:RKT)’s stock price reached a new 52-week high on Thursday . The stock traded as high as GBX 5,386 ($69.43) and last traded at GBX 5,356 ($69.04), with a volume of 15833262 shares. The stock had previously closed at GBX 5,186 ($66.85).

Reckitt Benckiser Group Price Performance

The stock has a market cap of £36.36 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. The company has a 50-day simple moving average of GBX 5,106.99 and a two-hundred day simple moving average of GBX 4,828.16. The company has a debt-to-equity ratio of 110.26, a quick ratio of 0.46 and a current ratio of 0.69.

Insider Buying and Selling

In related news, insider Shannon Eisenhardt sold 1,368 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of GBX 4,723 ($60.88), for a total value of £64,610.64 ($83,282.60). 0.05% of the stock is owned by insiders.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.